Brief: Medesis Pharma And Transgene Announce Joint European Patent

Medesis Pharma SA

01/09/2021 16:56

Sept 1 (Reuters) - MEDESIS PHARMA SA  ALMDP.PA :
    * TODAY ANNOUNCED JOINT FILING WITH TRANSGENE OF A EUROPEAN
PATENT
PROTECTING A NOVEL THERAPEUTIC APPROACH TO INHIBIT INTERFERON
GENE EXPRESSION
    * CNRS IS ALSO A STAKEHOLDER IN PATIENT

Source text for Eikon:  ID:nNDL4fRT9v 
Further company coverage:  ALMDP.PA ; TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))